Johnson & Johnson
JNJ172.775USD
-1.045-0.60%
종가 08/12, 16:00（ET）시세는 15분 지연됩니다
415.83B시가총액
19.07P/E TTM
자세한 내용은 Johnson & Johnson 회사
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).
회사 정보
종목 코드 JNJ
회사 이름Johnson & Johnson
상장일Sep 25, 1944
CEOMr. Joaquin Boix Duato
직원 수138100
유형Ordinary Share
회계 연도 종료Sep 25
주소One Johnson & Johnson Plaza
도시NEW BRUNSWICK
증권 거래소NYSE Consolidated
국가United States of America
우편 번호08933
전화17325242455
웹사이트https://www.jnj.com/
종목 코드 JNJ
상장일Sep 25, 1944
CEOMr. Joaquin Boix Duato
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
276.91K
-32.09%
Ms. Jennifer L. Taubert
Ms. Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Executive Vice President, Worldwide Chairman, Innovative Medicine
178.01K
+14.96%
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technology Officer and Risk Officer
Executive Vice President, Chief Technology Officer and Risk Officer
94.62K
+14.54%
Mr. Joseph J. Wolk
Mr. Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
84.95K
+4047.85%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Executive Vice President - Global Corporate Affairs
Executive Vice President - Global Corporate Affairs
23.59K
+18.96%
Ms. Kristen Mulholland
Ms. Kristen Mulholland
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
14.12K
+20.79%
Ms. Elizabeth (Liz) Forminard
Ms. Elizabeth (Liz) Forminard
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
10.90K
+30.72%
Prof. Dr. John C. Reed, M.D., Ph.D.
Prof. Dr. John C. Reed, M.D., Ph.D.
Executive Vice President - Innovative Medicine, Research and Development
Executive Vice President - Innovative Medicine, Research and Development
10.66K
-64.23%
Mrs. Anne M. Mulcahy
Mrs. Anne M. Mulcahy
Independent Director
Independent Director
8.41K
+3.87%
Mr. Hubert Joly
Mr. Hubert Joly
Independent Director
Independent Director
5.00K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
276.91K
-32.09%
Ms. Jennifer L. Taubert
Ms. Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Executive Vice President, Worldwide Chairman, Innovative Medicine
178.01K
+14.96%
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technology Officer and Risk Officer
Executive Vice President, Chief Technology Officer and Risk Officer
94.62K
+14.54%
Mr. Joseph J. Wolk
Mr. Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
84.95K
+4047.85%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Executive Vice President - Global Corporate Affairs
Executive Vice President - Global Corporate Affairs
23.59K
+18.96%
Ms. Kristen Mulholland
Ms. Kristen Mulholland
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
14.12K
+20.79%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Oncology-DARZALEX
3.24B
14.79%
Interventional Solutions
2.10B
9.61%
Immunology-STELARA
1.63B
7.42%
Surgery-General
1.32B
6.04%
Surgery-Advanced
1.07B
4.90%
Other
12.53B
57.24%
지역별USD
이름
수익
비율
United States
12.30B
56.21%
Europe
5.11B
23.34%
Asia-Pacific, Africa
3.31B
15.12%
Western Hemisphere, excluding U.S.
1.17B
5.33%
사업별
지역별
사업별USD
이름
수익
비율
Oncology-DARZALEX
3.24B
14.79%
Interventional Solutions
2.10B
9.61%
Immunology-STELARA
1.63B
7.42%
Surgery-General
1.32B
6.04%
Surgery-Advanced
1.07B
4.90%
Other
12.53B
57.24%
주식 보유 통계
마지막 업데이트: Tue, May 13
마지막 업데이트: Tue, May 13
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
9.80%
State Street Global Advisors (US)
5.56%
BlackRock Institutional Trust Company, N.A.
5.39%
Geode Capital Management, L.L.C.
2.52%
JP Morgan Asset Management
1.52%
Other
75.22%
주주
주주
비율
The Vanguard Group, Inc.
9.80%
State Street Global Advisors (US)
5.56%
BlackRock Institutional Trust Company, N.A.
5.39%
Geode Capital Management, L.L.C.
2.52%
JP Morgan Asset Management
1.52%
Other
75.22%
주주 유형
주주
비율
Investment Advisor
38.87%
Investment Advisor/Hedge Fund
23.78%
Research Firm
3.08%
Pension Fund
2.22%
Bank and Trust
2.18%
Insurance Company
1.64%
Sovereign Wealth Fund
1.36%
Hedge Fund
0.58%
Family Office
0.08%
Other
26.22%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
5920
1.78B
73.89%
-7.65M
2025Q1
6002
1.80B
74.62%
+4.60M
2024Q4
5953
1.78B
74.14%
+8.28M
2024Q3
5699
1.77B
73.47%
+2.69M
2024Q2
5691
1.75B
72.75%
+9.12M
2024Q1
5685
1.73B
71.58%
-6.08M
2023Q4
5686
1.72B
71.40%
-7.80M
2023Q3
5524
1.72B
71.21%
-159.24M
2023Q2
5528
1.87B
71.81%
+6.27M
2023Q1
5490
1.85B
71.21%
-28.44M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
232.98M
9.68%
+1.17M
+0.50%
Mar 31, 2025
State Street Global Advisors (US)
133.79M
5.56%
-666.37K
-0.50%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
129.14M
5.37%
-857.93K
-0.66%
Mar 31, 2025
Geode Capital Management, L.L.C.
59.38M
2.47%
+1.72M
+2.98%
Mar 31, 2025
JP Morgan Asset Management
35.25M
1.47%
+11.21M
+46.62%
Mar 31, 2025
State Farm Insurance Companies
34.37M
1.43%
--
--
Mar 31, 2025
Norges Bank Investment Management (NBIM)
30.36M
1.26%
+1.26M
+4.34%
Dec 31, 2024
Morgan Stanley Smith Barney LLC
24.07M
1%
+1.16M
+5.06%
Mar 31, 2025
Wellington Management Company, LLP
22.65M
0.94%
-1.71M
-7.02%
Mar 31, 2025
BlackRock Asset Management Ireland Limited
19.70M
0.82%
-178.45K
-0.90%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Wed, Aug 6
마지막 업데이트: Wed, Aug 6
이름
비율
iShares U.S. Pharmaceuticals ETF
23.85%
FT Vest DJIA Dogs 10 Target Income ETF
9.78%
VanEck Pharmaceutical ETF
8.38%
First Trust NASDAQ Pharmaceuticals ETF
8.12%
Health Care Select Sector SPDR Fund
7.51%
Proshares Ultra Health Care
7.51%
JPMorgan Healthcare Leaders ETF
7.42%
iShares U.S. Healthcare ETF
7.26%
iShares Core High Dividend ETF
6.49%
Fidelity MSCI Health Care Index ETF
6.48%
더 보기
iShares U.S. Pharmaceuticals ETF
비율23.85%
FT Vest DJIA Dogs 10 Target Income ETF
비율9.78%
VanEck Pharmaceutical ETF
비율8.38%
First Trust NASDAQ Pharmaceuticals ETF
비율8.12%
Health Care Select Sector SPDR Fund
비율7.51%
Proshares Ultra Health Care
비율7.51%
JPMorgan Healthcare Leaders ETF
비율7.42%
iShares U.S. Healthcare ETF
비율7.26%
iShares Core High Dividend ETF
비율6.49%
Fidelity MSCI Health Care Index ETF
비율6.48%
주식 배당금
지난 5년 동안 총
56.79B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Jan 02, 2025
JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Mar 04, 2025 going ex on Feb 18, 2025
Feb 18, 2025
Mar 04, 2025
Feb 18, 2025
Oct 15, 2024
JNJ.NB Final Cash Dividend of gross USD 1.24 paid on Dec 10, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 10, 2024
Nov 26, 2024
Jul 17, 2024
JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Sep 10, 2024 going ex on Aug 27, 2024
Aug 27, 2024
Sep 10, 2024
Aug 27, 2024
Apr 16, 2024
JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Jun 04, 2024 going ex on May 20, 2024
May 21, 2024
Jun 04, 2024
May 20, 2024
Jan 02, 2024
JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Mar 05, 2024 going ex on Feb 16, 2024
Feb 20, 2024
Mar 05, 2024
Feb 16, 2024
Oct 19, 2023
JNJ.NB Final Cash Dividend of gross USD 1.19 paid on Dec 05, 2023 going ex on Nov 20, 2023
Nov 21, 2023
Dec 05, 2023
Nov 20, 2023
Jul 20, 2023
JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
Apr 18, 2023
JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Jun 06, 2023 going ex on May 22, 2023
May 23, 2023
Jun 06, 2023
May 22, 2023
Jan 03, 2023
JNJ.NB Interim Cash Dividend of gross USD 1.13 paid on Mar 07, 2023 going ex on Feb 17, 2023
Feb 21, 2023
Mar 07, 2023
Feb 17, 2023
Oct 18, 2022
JNJ.NB Final Cash Dividend of gross USD 1.13 paid on Dec 06, 2022 going ex on Nov 21, 2022
Nov 22, 2022
Dec 06, 2022
Nov 21, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
